FDA Approves Impella 2.5 Blood Pump For Patients Undergoing High Risk Percutaneous Coronary Intervention (PCI) Procedures
Danvers, Massachusetts based in Abiomed, Inc., specialists in heart support technologies and circulatory boosting medical devices, has received U.S. Food and Drug Administration (FDA) Pre-Market Approval (PMA) for its Impella ... Read more